These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1594245)

  • 1. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE; Boehmelt G; Enrietto PJ
    Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
    Capobianco AJ; Gilmore TD
    Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.
    Capobianco AJ; Simmons DL; Gilmore TD
    Oncogene; 1990 Mar; 5(3):257-65. PubMed ID: 2179815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. v-rel- and c-rel-protein complexes bind to the NF-kappa B site in vitro.
    Kochel T; Rice NR
    Oncogene; 1992 Mar; 7(3):567-72. PubMed ID: 1549370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the carboxy terminus of v-Rel in transformation and activation of endogenous gene expression.
    Smardova J; Walker A; Morrison LE; Kabrun N; Enrietto PJ
    Oncogene; 1995 May; 10(10):2017-26. PubMed ID: 7761102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
    Sarkar S; Gilmore TD
    Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
    Gélinas C; Temin HM
    Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
    Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
    Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
    Bhat GV; Temin HM
    Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
    Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
    Xu X; Gélinas C
    Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.
    Petrenko O; Ischenko I; Enrietto PJ
    Oncogene; 1997 Oct; 15(14):1671-80. PubMed ID: 9349500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
    Zurovec M; Petrenko O; Roll R; Enrietto PJ
    Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.
    Nehyba J; Hrdlicková R; Bose HR
    Oncogene; 1997 Jun; 14(24):2881-97. PubMed ID: 9205096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of transformation by the v-rel oncogene.
    Hannink M; Temin HM
    Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the functional domains of the v-rel oncogene.
    Garson K; Kang CY
    Oncogene; 1990 Sep; 5(9):1431-4. PubMed ID: 2216467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.